Posted by Michael Wonder on 04 Apr 2022
Digital Medicine Society launches toolkit to support reimbursement for new drugs developed using digital outcomes
4 April 2022 - New essential resources ensure that patients will benefit without delay following regulatory acceptance of digital outcomes.
Today, the Digital Medicine Society, in partnership with Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer, and Savvy Co-op, announced the public launch of the 3Ps of Digital Endpoint Value, a toolkit of resources created to facilitate the inclusion of digital endpoints as evidence for payers in reimbursement decisions for new drugs.
